EPO and medulloblastoma: Additionally, MCs have been detected in increased numbers in the infiltrating zones of medulloblastomas and gliomas [55], while they were also found to be erythropoietin (EPO)-positive in 50 % of a series of hemangioblastoma specimens [56].